Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rajala

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Acta Paediatrica (Oslo, Norway : 1992)|May 15, 2026
Parent-Led Pain Management in Neonatal Care-Time to Move ForwardA Ullsten, F Bacchini, M Campbell-Yeo, et al.
Diabetes Care|March 30, 2007
Associations of total testosterone and sex hormone-binding globulin levels with insulin sensitivity in middle-aged Finnish menUlla M Rajala, Sirkka M Keinänen-Kiukaanniemi, Paivi K Hirsso, et al.
Blood Cancer Journal|December 10, 2013
Novel somatic mutations in large granular lymphocytic leukemia affecting the STAT-pathway and T-cell activationE I Andersson, H L M Rajala, S Eldfors, et al.
Diabetes Care|August 29, 2006
Association between high-sensitive measurement of C-reactive protein and metabolic syndrome as defined by International Diabetes Federation, National Cholesterol Education Program, and World Health Organization criteria in a population-based cohort of 55-year-old Finnish individualsPäivi K Hirsso, Markku J Timonen, Jari J Jokelainen, et al.
Leukemia|October 14, 2014
Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998)T P Loughran, L Zickl, T L Olson, et al.
Journal of Cancer Research and Clinical Oncology|March 25, 2017
Tyrosine kinase inhibitor therapy-induced changes in humoral immunity in patients with chronic myeloid leukemiaHanna L M Rajala, Mohamed El Missiry, Anniina Ruusila, et al.
Haematologica|October 5, 2014
The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemiaHanna L M Rajala, Thomas Olson, Michael J Clemente, et al.
Blood|April 19, 2013
Discovery of somatic STAT5b mutations in large granular lymphocytic leukemiaHanna L M Rajala, Samuli Eldfors, Heikki Kuusanmäki, et al.
Blood|October 29, 2014
Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3Emma M Haapaniemi, Meri Kaustio, Hanna L M Rajala, et al.
Regenerative Medicine|February 13, 2015
Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI)P W Andrews, D Baker, N Benvinisty, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Acta Paediatrica (Oslo, Norway : 1992)|May 15, 2026
Parent-Led Pain Management in Neonatal Care-Time to Move ForwardA Ullsten, F Bacchini, M Campbell-Yeo, et al.
Diabetes Care|March 30, 2007
Associations of total testosterone and sex hormone-binding globulin levels with insulin sensitivity in middle-aged Finnish menUlla M Rajala, Sirkka M Keinänen-Kiukaanniemi, Paivi K Hirsso, et al.
Blood Cancer Journal|December 10, 2013
Novel somatic mutations in large granular lymphocytic leukemia affecting the STAT-pathway and T-cell activationE I Andersson, H L M Rajala, S Eldfors, et al.
Diabetes Care|August 29, 2006
Association between high-sensitive measurement of C-reactive protein and metabolic syndrome as defined by International Diabetes Federation, National Cholesterol Education Program, and World Health Organization criteria in a population-based cohort of 55-year-old Finnish individualsPäivi K Hirsso, Markku J Timonen, Jari J Jokelainen, et al.
Leukemia|October 14, 2014
Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998)T P Loughran, L Zickl, T L Olson, et al.
Journal of Cancer Research and Clinical Oncology|March 25, 2017
Tyrosine kinase inhibitor therapy-induced changes in humoral immunity in patients with chronic myeloid leukemiaHanna L M Rajala, Mohamed El Missiry, Anniina Ruusila, et al.
Haematologica|October 5, 2014
The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemiaHanna L M Rajala, Thomas Olson, Michael J Clemente, et al.
Blood|April 19, 2013
Discovery of somatic STAT5b mutations in large granular lymphocytic leukemiaHanna L M Rajala, Samuli Eldfors, Heikki Kuusanmäki, et al.
Blood|October 29, 2014
Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3Emma M Haapaniemi, Meri Kaustio, Hanna L M Rajala, et al.
Regenerative Medicine|February 13, 2015
Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI)P W Andrews, D Baker, N Benvinisty, et al.
Pageof 7